share_log

智飞生物:四价流感疫苗临床试验申请获受理

JRJ Finance ·  Jul 29 06:39

智飞生物公告,公司全资子公司智飞龙科马研发的佐剂四价流感疫苗获得国家药品监督管理局药物临床试验申请受理通知书。若60日内未收到否定或质疑意见,智飞龙科马可开展临床试验。该疫苗含自主研制的ZFA02佐剂,用于预防流感病毒引起的流感。

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment